tradingkey.logo

IRIDEX Corp

IRIX

1.190USD

-0.090-7.03%
Close 09/19, 16:00ETQuotes delayed by 15 min
20.01MMarket Cap
LossP/E TTM

IRIDEX Corp

1.190

-0.090-7.03%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
143 / 207
Overall Ranking
406 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Growing
The company is in a growing phase, with the latest annual income totaling USD 48.67M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 18.06.
Undervalued
The company’s latest PE is -3.67, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 7.58M shares, increasing 4.37% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 585.81K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.39.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.49, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 13.57M, representing a year-over-year increase of 7.44%, while its net profit experienced a year-over-year increase of 62.90%.

Score

Industry at a Glance

Previous score
6.49
Change
0

Financials

6.55

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

6.41

Operational Efficiency

6.51

Growth Potential

5.91

Shareholder Returns

7.09

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -3.95, which is -41.03% below the recent high of -2.33 and 20.99% above the recent low of -3.12.

Score

Industry at a Glance

Previous score
2.80
Change
1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 143/207
No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.70.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

No Data
No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 6.57, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 1.43 and the support level at 1.16, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.57
Change
-0.43

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.036
Neutral
RSI(14)
40.402
Neutral
STOCH(KDJ)(9,3,3)
7.402
Oversold
ATR(14)
0.079
High Vlolatility
CCI(14)
-191.710
Sell
Williams %R
96.552
Oversold
TRIX(12,20)
0.161
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
1.264
Sell
MA10
1.307
Sell
MA20
1.314
Sell
MA50
1.278
Sell
MA100
1.143
Buy
MA200
1.274
Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 45.15%, representing a quarter-over-quarter increase of 13.20%. The largest institutional shareholder is The Vanguard, holding a total of 585.81K shares, representing 3.45% of shares outstanding, with 2.22% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Topcon Corp
1.62M
+0.37%
Stanley Manne Trust
1.07M
--
Paragon JV Partners, LLC
1.00M
--
The Vanguard Group, Inc.
Star Investors
594.79K
+6.00%
Roland (Brent Alexander)
461.71K
--
Renaissance Technologies LLC
Star Investors
379.16K
-0.52%
Moore (William M)
287.98K
+21.01%
Roland Family Support Trust
223.69K
--
AMH Equity, Ltd.
518.54K
+3.48%
Roland (Glenn Cuthbert)
181.60K
--
1
2

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.18, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.63. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.18
Change
0
Beta vs S&P 500 index
0.63
VaR
+5.95%
240-Day Maximum Drawdown
+58.49%
240-Day Volatility
+86.00%
Return
Best Daily Return
60 days
+20.56%
120 days
+20.56%
5 years
+44.41%
Worst Daily Return
60 days
-9.23%
120 days
-9.27%
5 years
-34.76%
Sharpe Ratio
60 days
+1.97
120 days
+1.34
5 years
+0.26
Risk Assessment
Maximum Drawdown
240 days
+58.49%
3 years
+77.62%
5 years
+91.57%
Return-to-Drawdown Ratio
240 days
-0.43
3 years
-0.18
5 years
-0.07
Skewness
240 days
+1.46
3 years
+0.29
5 years
+1.31
Volatility
Realised Volatility
240 days
+86.00%
5 years
+85.57%
Standardised True Range
240 days
+7.01%
5 years
+16.40%
Downside Risk-Adjusted Return
120 days
+244.19%
240 days
+244.19%
Maximum Daily Upside Volatility
60 days
+87.07%
Maximum Daily Downside Volatility
60 days
+46.33%
Liquidity
Average Turnover Rate
60 days
+0.70%
120 days
+0.66%
5 years
--
Turnover Deviation
20 days
+38.63%
60 days
+80.69%
120 days
+70.89%

Peer Comparison

Healthcare Equipment & Supplies
IRIDEX Corp
IRIDEX Corp
IRIX
4.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
Stevanato Group SpA
STVN
8.24 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Abbott Laboratories
Abbott Laboratories
ABT
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Transmedics Group Inc
Transmedics Group Inc
TMDX
8.01 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI